Resources for clinicians to help you treat pregnant women and mothers with opioid use disorder and their infants.
- Practice Guidance
- Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants (SAMHSA)
- Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy (WHO)
- Opioid Use and Opioid Use Disorder in Pregnancy: ACOG Committee Opinion (ACOG/ASAM)
- National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use: See Part 8 – Special Populations: Pregnant Women (ASAM)
- A Public Health Response to Opioid Use in Pregnancy: Policy Statement (AAP)
- Neonatal Drug Withdrawal: Policy Statement (AAP)
- Guidelines for Breastfeeding and Substance Use or Substance Use Disorder (ABM)
- Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction: See Chapter 5 – Special Populations (SAMHSA, CSAT)
- Postpartum Pain Management: ACOG Committee Opinion (ACOG)
- Research & News
- Further Education
- Treating Opioid Use During Pregnancy (NIDA)
- A collaborative approach to the treatment of pregnant women with OUD (SAMHSA)
- Webinar Series on Opioid Use Disorders and Treatment – "Webinar series on medication-assisted treatment for families affected by substance use disorders, opioid use in pregnancy and treatment for Neonatal Abstinence Syndrome." (NCSACW, SAMHSA)